Copy number alterations analysis of primary tumor tissue and circulating tumor cells from patients with early-stage triple negative breast cancer

Triple negative breast cancer (TNBC) is characterized by clinical aggressiveness, lack of recognized target therapy, and a dismal patient prognosis. Several studies addressed genomic changes occurring during neoadjuvant chemotherapy (NAC) focusing on somatic variants, but without including copy numb...

Descripción completa

Detalles Bibliográficos
Autores principales: Silvestri, Marco, Dugo, Matteo, Vismara, Marta, De Cecco, Loris, Lanzoni, Davide, Vingiani, Andrea, Folli, Secondo, De Santis, Maria Carmen, de Braud, Filippo, Pruneri, Giancarlo, Di Cosimo, Serena, Cappelletti, Vera
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795239/
https://www.ncbi.nlm.nih.gov/pubmed/35087134
http://dx.doi.org/10.1038/s41598-022-05502-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795239/
https://www.ncbi.nlm.nih.gov/pubmed/35087134
http://dx.doi.org/10.1038/s41598-022-05502-6

Ejemplares similares